Literature DB >> 3623074

Basal and stimulated adenylate cyclase activity in the gill epithelium of the rainbow trout.

M Guibbolini, B Lahlou.   

Abstract

Basal and stimulated adenylate cyclase specific activity was characterized in gill plasma membrane of freshwater-adapted trout by measuring the conversion of [alpha-32P]ATP into [alpha-32P]cyclic AMP. Both basal and isoproterenol- or sodium fluoride-stimulated enzyme activities were linear with time and protein concentration. The optimum activities were obtained using a pH buffer of 7.5 and a temperature of 20 degrees. The Km for ATP was 0.5 mM in the presence or absence of the stimulators. The presence of 10(-5) M guanosine-5'-triphosphate and 4 X 10(-3) M MgCl2 (2.41 X 10(-3) M free Mg2+) was required to optimize not only the basal activity but also the stimulation ratio (test/control) produced by these agents. On the contrary, Ca2+ was inhibitory. IC50 for CaCl2 was 5 X 10(-4) M (10(-7) M free Ca2+) in the presence or absence of the stimulators. Under these conditions, the basal adenylate cyclase specific activity was 400-450 pmol/mg protein/10 min. A maximal stimulation was produced by isoproterenol or PGE1 10(-5) M (50% increase over basal activity) or by glucagon 5.7 X 10(-10) M (30%). In addition, this enzyme displayed high sensitivity to sodium fluoride which induced a particularly large maximal effect (370%) at a concentration of 10(-2) M.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3623074     DOI: 10.1016/0016-6480(87)90146-8

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  2 in total

1.  Regulation of Cl- secretion in seawater fish (Dicentrarchus labrax) gill respiratory cells in primary culture.

Authors:  M Avella; P Part; J Ehrenfeld
Journal:  J Physiol       Date:  1999-04-15       Impact factor: 5.182

2.  Natriuretic peptides inhibit adenylyl cyclase activity in dispersed eel gill cells.

Authors:  W Callahan; S Nankervis; T Toop
Journal:  J Comp Physiol B       Date:  2004-02-04       Impact factor: 2.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.